Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Frequency Therapeutics, Inc. (FREQ) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/25/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : September 23, 2020 FREQUENCY THERAPEUTICS, INC. Delaware 001-39062 47-2324450 19 Presidential Way, 2nd Floor Woburn, MA 01801 389-1970 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 un...",
"Amended and Restated Bylaws of Frequency Therapeutics, Inc., effective as of September 23, 2020",
"Frequency Therapeutics Appoints Cynthia Feldmann to its Board of Directors"
08/12/2020 8-K Quarterly results
07/21/2020 8-K Quarterly results
06/12/2020 8-K Submission of Matters to a Vote of Security Holders
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : June 11, 2020 FREQUENCY THERAPEUTICS, INC. Delaware 001-39062 47-2324450 19 Presidential Way, 2nd Floor Woburn, MA 01801 389-1970 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under t..."
05/14/2020 8-K Quarterly results
04/30/2020 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Letter to Stockholders",
"Letter to Stockholders"
03/26/2020 8-K Quarterly results
01/13/2020 8-K Entry into a Material Definitive Agreement
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : January 13, 2020 FREQUENCY THERAPEUTICS, INC. Delaware 001-39062 47-2324450 19 Presidential Way, 2nd Floor Woburn, MA 01801 389-1970 N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 unde..."
11/18/2019 8-K Quarterly results
11/14/2019 8-K Quarterly results
10/07/2019 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy